These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29443804)

  • 1. PROGRESSION OF RETINAL ISCHEMIA IN A CASE OF MACULAR TELANGIECTASIA TYPE 1 AFTER RANIBIZUMAB INJECTION: OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS.
    Lorusso M; Zito R; Nikolopoulou E; Micelli Ferrari L; Cicinelli MV; Querques G; Micelli Ferrari T
    Retin Cases Brief Rep; 2020; 14(4):372-376. PubMed ID: 29443804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT AT 2-MONTH INTERVALS REDUCES FOVEAL AVASCULAR ZONE ENLARGEMENT AND VISION LOSS IN RADIATION MACULOPATHY: A Pilot Study.
    Daruich A; Matet A; Schalenbourg A; Zografos L
    Retina; 2019 Aug; 39(8):1519-1526. PubMed ID: 29746413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab.
    Ebneter A; Wolf S; Zinkernagel MS
    Br J Ophthalmol; 2016 Mar; 100(3):365-70. PubMed ID: 26187951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to anti-vascular endothelial growth factor of abnormal retinal vascular net in para foveal telangiectasia group II images on optical coherence tomography-angiography.
    Saoji K; Pathengay A; Chhablani J; Panchal B; Doshi S; Saldanha M
    Indian J Ophthalmol; 2019 Jan; 67(1):105-108. PubMed ID: 30574903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RETINAL MICROVASCULATURE AND VISUAL ACUITY AFTER INTRAVITREAL AFLIBERCEPT IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study.
    Winegarner A; Wakabayashi T; Hara-Ueno C; Sato T; Busch C; Fukushima Y; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
    Retina; 2018 Oct; 38(10):2067-2072. PubMed ID: 28902097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization.
    Do DV; Bressler SB; Cassard SD; Gower EW; Tabandeh H; Jefferys JL; Bressler NM
    Retina; 2014 Oct; 34(10):2063-71. PubMed ID: 24978428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
    Kovach JL; Rosenfeld PJ
    Retina; 2009 Jan; 29(1):27-32. PubMed ID: 18936721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of OCT angiography in children with a history of intravitreal injection of ranibizumab versus laser photocoagulation for retinopathy of prematurity.
    Zhao J; Wu Z; Lam W; Yang M; Chen L; Zheng L; Zhang F; Zeng J; Wang J; Zhang G
    Br J Ophthalmol; 2020 Nov; 104(11):1556-1560. PubMed ID: 32051137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
    Lee JY; Chung H; Kim HC
    Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The macular function and structure in patients with diabetic macular edema before and after ranibizumab treatment.
    Nowacka B; Kirkiewicz M; Mozolewska-Piotrowska K; Lubiński W
    Doc Ophthalmol; 2016 Apr; 132(2):111-22. PubMed ID: 27000269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranibizumab treatment for choroidal neovascularization secondary to causes other than age-related macular degeneration with good baseline visual acuity.
    Erol MK; Ozdemir O; Coban DT; Ceran BB; Bulut M
    Semin Ophthalmol; 2014 Mar; 29(2):108-13. PubMed ID: 24409939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APPLICATION OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY TO ASSESS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Cheng Y; Li Y; Huang X; Qu Y
    Retina; 2019 Apr; 39(4):712-718. PubMed ID: 29256987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history and effect of therapeutic interventions on subretinal fluid causing foveal detachment in macular telangiectasia type 2.
    Mehta H; Müller S; Egan CA; Degli Esposti S; Tufail A; Sim DA; Holz FG; Browning AC; Amoaku WM; Charbel Issa P; Gillies MC
    Br J Ophthalmol; 2017 Jul; 101(7):955-959. PubMed ID: 27793821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the impact of summer vacation on the visual acuity of AMD patients treated with ranibizumab.
    Massamba N; Dirani A; Knoeri J; Pasquier B; Ingram A; Soubrane G
    Eye (Lond); 2015 Nov; 29(11):1453-7. PubMed ID: 26206530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomical and visual outcomes of ranibizumab injections in retinal pigment epithelium tears.
    Erol MK; Ozdemir O; Coban DT; Ceran BB; Sari ES
    Arq Bras Oftalmol; 2015; 78(3):168-72. PubMed ID: 26222106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.
    Tilleul J; Mimoun G; Querques G; Puche N; Zerbib J; Lalloum F; Srour M; Souied EH
    Retina; 2016 Mar; 36(3):483-91. PubMed ID: 26355947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macular vessel reduction as predictor for recurrence of macular oedema requiring repeat intravitreal ranibizumab injection in eyes with branch retinal vein occlusion.
    Hasegawa T; Takahashi Y; Maruko I; Kogure A; Iida T
    Br J Ophthalmol; 2019 Oct; 103(10):1367-1372. PubMed ID: 30514711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.